Gene · 2230
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SIRT5-mediated FDX1 desuccinylation confers cuproptosis resistance in lung adenocarcinoma. | Cell Rep | 2026 | 42228571 | PubTator, text mining | PubMed |
| An autoantibody signature targeting cuproptosis-related proteins for non-small cell lung cancer detection and prognosis. | PeerJ | 2026 | 42222481 | PubTator, text mining | PubMed |
| CHD4 is a copper sensor linking chromatin remodeling to cuproptosis. | Free Radic Biol Med | 2026 | 42176908 | PubTator, text mining | PubMed |
| The role of cuproptosis in osteoporosis: Molecular mechanisms and cell-specific regulation in bone metabolic imbalance. | Tissue Cell | 2026 | 42176681 | PubTator, text mining | PubMed |
| IGF2BP2 promotes cuproptosis of cardiomyocytes through m6A modification of MAP2K1 in sepsis-induced myocardial injury. | Cell Immunol | 2026 | 42167092 | PubTator, text mining | PubMed |
| Licochalcone a Disrupted Mitochondrial Function to Promote Cuproptosis in Glioblastoma Through Regulating RAS/MAPK Pathway. | Appl Biochem Biotechnol | 2026 | 42156627 | PubTator, text mining | PubMed |
| Adrenal-derived factors drive progression of sclerotic prostate cancer in bone. | Endocr Relat Cancer | 2026 | 42149634 | PubTator, text mining | PubMed |
| Orchestrating mitochondrial catastrophe: Mechanistic insights and therapeutic frontiers of cuproptosis in precision pharmacology. | Curr Opin Pharmacol | 2026 | 42114175 | PubTator, text mining | PubMed |
| FDX1 as a predictive biomarker and therapeutic target for lymph node metastasis in gastric cancer. | Clin Exp Med | 2026 | 42107026 | PubTator, text mining | PubMed |
| Research Progress on Elesclomol-Induced Cuproptosis for Antitumor Effects. | Biomedicines | 2026 | 42072452 | PubTator, text mining | PubMed |
| AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1. | Proc Natl Acad Sci U S A | 2026 | 42066048 | PubTator, text mining | PubMed |
| Resveratrol inhibits aerobic glycolysis and promotes cuproptosis in acute myeloid leukemia via the PI3K/AKT signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42056286 | PubTator, text mining | PubMed |
| [Ursolic acid in Huajie Xiaoliu Formula inhibits colorectal cancer cell growth by inducing cuproptosis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | 42045033 | PubTator, text mining | PubMed |
| GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation. | Mol Pharm | 2026 | 42044237 | PubTator, text mining | PubMed |
| ASPP2 inhibits hepatocellular carcinoma growth by regulating cuproptosis via mitochondrial protein lipoylation. | Cell Death Dis | 2026 | 42031700 | PubTator, text mining | PubMed |
| Advanced Glycation End Products Induce Cuproptosis and Then Promote the Activation and Migration of Cardiac Fibroblasts. | Int J Toxicol | 2026 | 42010979 | PubTator, text mining | PubMed |
| Fucoidan-Copper Nanoparticles to Potentiate Cancer Cell Cuproptosis and Tumor Immune Microenvironment Enhancement. | ACS Appl Mater Interfaces | 2026 | 42007647 | PubTator, text mining | PubMed |
| Emodin triggers cuproptosis to suppress hepatocellular carcinoma via SLC7A11/FDX1 axis. | Front Oncol | 2026 | 41959927 | PubTator, text mining | PubMed |
| Progress in the Research of Cuproptosis and Possible Targets for Gynecological Cancers. | J Biochem Mol Toxicol | 2026 | 41944514 | PubTator, text mining | PubMed |
| [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2230/papers?page=4